Structural Evolution and Dynamics of the p53 Proteins

被引：41

作者：

Chillemi, Giovanni ^{[1
]}

Kehrloesser, Sebastian ^{[2
]}

Bernassola, Francesca ^{[3
]}

Desideri, Alessandro ^{[4
]}

Doetsch, Volker ^{[2
]}

Levine, Arnold J. ^{[5
,6
]}

Melino, Gerry ^{[7
]}

机构：

[1] CINECA, SCAI SuperComp Applicat & Innovat Dept, I-00185 Rome, Italy

[2] Goethe Univ, Inst Biophys Chem, D-60438 Frankfurt, Germany

[3] Univ Roma Tor Vergata, Dept Expt Med & Surg, I-00133 Rome, Italy

[4] Univ Roma Tor Vergata, Biol Dept, I-00133 Rome, Italy

[5] Inst Adv Study, Olden Lane, Princeton, NJ 08540 USA

[6] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA

[7] Univ Leicester, Toxicol Unit, Med Res Council, Leicester LE1 9HN, Leics, England

来源：

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE | 2017年 / 7卷 / 04期

基金：

英国医学研究理事会;

关键词：

TUMOR-SUPPRESSOR P53; DNA-BINDING DOMAIN; C-TERMINAL DOMAIN; TETRAMERIZATION DOMAIN; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; MUTANT P53; MATERNAL REPRODUCTION; ENZYME SPECIFICITY; FUNCTIONAL DOMAIN;

D O I：

10.1101/cshperspect.a028308

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The family of the p53 tumor suppressive transcription factors includes p73 and p63 in addition to p53 itself. Given the high degree of amino-acid-sequence homology and structural organization shared by the p53 family members, they display some common features (i.e., induction of cell death, cell-cycle arrest, senescence, and metabolic regulation in response to cellular stress) as well as several distinct properties. Here, we describe the structural evolution of the family members with recent advances on the molecular dynamic studies of p53 itself. A crucial role of the carboxy-terminal domain in regulating the properties of the DNA-binding domain (DBD) supports an induced-fit mechanism, in which the binding of p53 on individual promoters is preferentially regulated by the K-OFF over K-ON.

引用

页数：15

共 50 条

[31] Molecular Architecture of Tumor Suppressor p53
Viadiu, Hector
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (15) : 1327 - 1334
[32] Autoantibody recognition mechanisms of p53 epitopes
Phillips, J. C.
PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS, 2016, 451 : 162 - 170
[33] The missing Zinc: p53 misfolding and cancer
Loh, Stewart N.
METALLOMICS, 2010, 2 (07) : 442 - 449
[34] Electron microscopy studies on the quaternary structure of p53 reveal different binding modes for p53 tetramers in complex with DNA
Melero, Roberto
Rajagopalan, Sridharan
Lazaro, Melisa
Joerger, Andreas C.
Brandt, Tobias
Veprintsev, Dmitry B.
Lasso, Gorka
Gil, David
Scheres, Sjors H. W.
Maria Carazo, Jose
Fersht, Alan R.
Valle, Mikel
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (02) : 557 - 562
[35] Anti-cancer Peptides from Ras-P21 and P53 Proteins
Pincus, Matthew R.
Fenelus, Maly
Sarafraz-Yazdi, Ehsan
Adler, Victor
Bowne, Wilbur
Michl, Josef
CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (25) : 2677 - 2698
[36] A Chimeric p53 Evades Mutant p53 Transdominant Inhibition in Cancer Cells
Okal, Abood
Mossalam, Mohanad
Matissek, Karina J.
Dixon, Andrew S.
Moos, Philip J.
Lim, Carol S.
MOLECULAR PHARMACEUTICS, 2013, 10 (10) : 3922 - 3933
[37] The "readers" of unacetylated p53 represent a new class of acidic domain proteins
Wang, Donglai
Kon, Ning
Tavana, Omid
Gu, Wei
NUCLEUS, 2017, 8 (04) : 360 - 369
[38] New Insights into the Role of DNA Shape on Its Recognition by p53 Proteins
Golovenko, Dmitrij
Braeuning, Bastian
Vyas, Pratik
Haran, Tali E.
Rozenberg, Haim
Shakked, Zippora
STRUCTURE, 2018, 26 (09) : 1237 - +
[39] p53 tetramerization: at the center of the dominant-negative effect of mutant p53
Gencel-Augusto, Jovanka
Lozano, Guillermina
GENES & DEVELOPMENT, 2020, 34 (17-18) : 1128 - 1146
[40] Molecular mechanisms of functional rescue mediated by P53 tumor suppressor mutations
Tan, Yu-Hong
Chen, Y. Morris
Ye, Xiang
Lu, Qiang
Tretyachenko-Ladokhina, Vira
Yang, Wei
Senear, Donald F.
Luo, Ray
BIOPHYSICAL CHEMISTRY, 2009, 145 (01) : 37 - 44

← 1 2 3 4 5 →